🔓 Unlock the full profile of Selin Kurnaz (Massive Bio), including verified contact details, financial insights, and professional associations.
See Selin Kurnaz Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: sel*****@mas******.com
Mobile: 78983*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Selin Kurnaz is the Co-Founder and CEO of Massive Bio, a company established in 2014, focused on improving cancer care through technology.
- Under Kurnaz's leadership, Massive Bio has developed a platform that matches cancer patients with clinical trials, leveraging data analytics to enhance treatment options and outcomes.
- Massive Bio has experienced significant growth, with a 179% increase in headcount over the past twelve months, indicating a strong demand for its services within the healthcare sector.
- Kurnaz is also an Investment Steering Committee Member for Volitan Global since January 2019, facilitating investment decisions in innovative startups.
- Prior to Massive Bio, Kurnaz played a pivotal role as a Philips HealthWorks Fellow, where insights into health technology innovations contributed to the development of new solutions.
- As an ELabNYC Fellow from 2017, Kurnaz gained exposure and mentorship within the health tech ecosystem, fostering entrepreneurial skills and strategic thinking.
- Kurnaz held senior positions at Ernst & Young, where responsibilities as Senior Manager in Transaction Advisory Services included advising on complex business transactions, showcasing expertise in business operations.
- Massive Bio has established a notable online presence, expanding its visibility through platforms like LinkedIn and Twitter, further supporting outreach to patients and healthcare professionals.
- With a strong commitment to enhancing patient access to clinical trials, Kurnaz's initiatives have the potential to significantly impact the treatment landscape for cancer patients.